Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria

NCT01642017 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT01642017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01642017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria
Lead sponsor
Institut Claudius Regaud
Phase
Phase 1
Overall status
Terminated
Start date
November 22, 2012
Completion date
March 31, 2018
Enrollment
18 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer (different solid tumour types)